87 related articles for article (PubMed ID: 27881006)
1. Decreased expression of MS4A12 inhibits differentiation and predicts early stage survival in colon cancer.
He L; Deng HY; C Wang X
Neoplasma; 2017; 64(1):65-73. PubMed ID: 27881006
[TBL] [Abstract][Full Text] [Related]
2. MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes.
Koslowski M; Sahin U; Dhaene K; Huber C; Türeci O
Cancer Res; 2008 May; 68(9):3458-66. PubMed ID: 18451174
[TBL] [Abstract][Full Text] [Related]
3. Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2.
Koslowski M; Türeci O; Huber C; Sahin U
Mol Cancer; 2009 Sep; 8():77. PubMed ID: 19781065
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.
Zhou E; Huang Q; Wang J; Fang C; Yang L; Zhu M; Chen J; Chen L; Dong M
Int J Clin Exp Pathol; 2015; 8(7):8018-27. PubMed ID: 26339368
[TBL] [Abstract][Full Text] [Related]
5. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.
Song G; Xu S; Zhang H; Wang Y; Xiao C; Jiang T; Wu L; Zhang T; Sun X; Zhong L; Zhou C; Wang Z; Peng Z; Chen J; Wang X
J Exp Clin Cancer Res; 2016 Sep; 35(1):148. PubMed ID: 27644693
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma.
Yao HS; Wang J; Zhang XP; Wang LZ; Wang Y; Li XX; Jin KZ; Hu ZQ; Wang WJ
Mol Carcinog; 2016 May; 55(5):458-72. PubMed ID: 25808746
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
[TBL] [Abstract][Full Text] [Related]
8. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
Brunschwig EB; Wilson K; Mack D; Dawson D; Lawrence E; Willson JK; Lu S; Nosrati A; Rerko RM; Swinler S; Beard L; Lutterbaugh JD; Willis J; Platzer P; Markowitz S
Cancer Res; 2003 Apr; 63(7):1568-75. PubMed ID: 12670906
[TBL] [Abstract][Full Text] [Related]
9. Screening of Differentiation-Specific Molecular Biomarkers for Colon Cancer.
Qi L; Ding Y
Cell Physiol Biochem; 2018; 46(6):2543-2550. PubMed ID: 29742509
[TBL] [Abstract][Full Text] [Related]
10. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis.
Yue B; Qiu S; Zhao S; Liu C; Zhang D; Yu F; Peng Z; Yan D
J Gastroenterol Hepatol; 2016 Mar; 31(3):595-603. PubMed ID: 26487301
[TBL] [Abstract][Full Text] [Related]
11. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
[TBL] [Abstract][Full Text] [Related]
12. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
[TBL] [Abstract][Full Text] [Related]
13. Derlin-1 is overexpressed in human colon cancer and promotes cancer cell proliferation.
Tan X; He X; Jiang Z; Wang X; Ma L; Liu L; Wang X; Fan Z; Su D
Mol Cell Biochem; 2015 Oct; 408(1-2):205-13. PubMed ID: 26173415
[TBL] [Abstract][Full Text] [Related]
14. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-driven gene expression is an independent prognostic factor in stage II and III colon cancer patients.
Dekervel J; Hompes D; van Malenstein H; Popovic D; Sagaert X; De Moor B; Van Cutsem E; D'Hoore A; Verslype C; van Pelt J
Clin Cancer Res; 2014 Apr; 20(8):2159-68. PubMed ID: 24486594
[TBL] [Abstract][Full Text] [Related]
16. SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity.
Barbáchano A; Ordóñez-Morán P; García JM; Sánchez A; Pereira F; Larriba MJ; Martínez N; Hernández J; Landolfi S; Bonilla F; Pálmer HG; Rojas JM; Muñoz A
Oncogene; 2010 Aug; 29(34):4800-13. PubMed ID: 20543868
[TBL] [Abstract][Full Text] [Related]
17. Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer.
Huang Z; Ai Z; Li N; Xi H; Gao X; Wang F; Tan X; Liu H
Cancer Biomark; 2016; 17(4):445-455. PubMed ID: 28085015
[TBL] [Abstract][Full Text] [Related]
18. Dual inhibition of COX-2/5-LOX blocks colon cancer proliferation, migration and invasion in vitro.
Che XH; Chen CL; Ye XL; Weng GB; Guo XZ; Yu WY; Tao J; Chen YC; Chen X
Oncol Rep; 2016 Mar; 35(3):1680-8. PubMed ID: 26707712
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells.
Aleman MJ; DeYoung MP; Tress M; Keating P; Perry GW; Narayanan R
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12765-70. PubMed ID: 16129820
[TBL] [Abstract][Full Text] [Related]
20. Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer.
Zhang M; Cui F; Lu S; Lu H; Xue Y; Wang J; Chen J; Zhao S; Ma S; Zhang Y; Yu Y; Peng Z; Tang H
J Exp Clin Cancer Res; 2015 Jun; 34(1):60. PubMed ID: 26063247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]